EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autophagy in Crohn’s Disease: Converging on Dysfunctional Innate Immunity

Kibrom M Alula iD, Arianne L Theiss iD

Cells · 04.07.2023 · 12 (13) · 1779

DOI: 10.3390/cells12131779 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.07.2023. Verfasst von Kibrom M Alula und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & Hepatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Crohn’s Colitis Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn’s disease (CD) is a chronic inflammatory bowel disease marked by relapsing, transmural intestinal inflammation driven by innate and adaptive immune responses. Autophagy is a multi-step process that plays a critical role in maintaining cellular homeostasis by degrading intracellular components, such as damaged organelles and invading bacteria. Dysregulation of autophagy in CD is revealed by the identification of several susceptibility genes, including ATG16L1, IRGM, NOD2, LRRK2, ULK1, ATG4, and TCF4, that are involved in autophagy. In this review, the role of altered autophagy in the mucosal innate immune response in the context of CD is discussed, with a specific focus on dendritic cells, macrophages, Paneth cells, and goblet cells. Selective autophagy, such as xenophagy, ERphagy, and mitophagy, that play crucial roles in maintaining intestinal homeostasis in these innate immune cells, are discussed. As our understanding of autophagy in CD pathogenesis evolves, the development of autophagy-targeted therapeutics may benefit subsets of patients harboring impaired autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseInflammatory Bowel DiseasesHumansImmunity, InnateIntestinesAutophagy

Stichwörter der Autor:innen

ATG16L1Crohn’s diseaseER stressIRGMNOD2genetic susceptibilityinflammatory bowel diseaseinnate immunitymitochondriamitophagyxenophagy

Autor:innen und Institutionen

  • Division of Gastroenterology & Hepatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

ORCID-Profile: Kibrom M Alula, Arianne L Theiss

Förderung

  • NIDDK NIH HHS
  • Crohn’s Colitis Foundation
  • National Institutes of Health

Zitieren

APA

Alula, K. M., & Theiss, A. L. (2023). Autophagy in Crohn’s Disease: Converging on Dysfunctional Innate Immunity. Cells, 12(13), 1779. https://doi.org/10.3390/cells12131779

Vancouver

Alula KM, Theiss AL. Autophagy in Crohn’s Disease: Converging on Dysfunctional Innate Immunity. Cells. 2023;12(13):1779. doi:10.3390/cells12131779

BibTeX
@article{Alula2023,
  author = {Alula, Kibrom M and Theiss, Arianne L},
  title = {Autophagy in Crohn’s Disease: Converging on Dysfunctional Innate Immunity},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {13},
  pages = {1779},
  doi = {10.3390/cells12131779}
}
Kostenlos starten →